Lab Experiment


The global precision medicine and genomics market is attracting huge investment towards the promise of transforming outcomes for cancer, rare diseases and reproductive health by personalizing treatments to a patients’ individual genetic makeup. 

New discoveries are being made on a almost daily basis, but to date the tests and treatments involved are expensive and overwhelmingly based on data drawn from Western European patients. 

Now Redcliffe Life Sciences, a leading multi-line genomics company from India, has entered the UK market as a launchpad for global expansion.


Redcliffe Biosciences, C/o Day & Co, Scottish Provident House, 76-80 College Rd, Harrow, London, UK, HA1 1BQ

What are you contacting us about?

Already a customer and need specific product support. Contact us here.